These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16859256)

  • 1. Clinical progression and familial occurrence of cerebral cavernous angiomas: the role of angiogenic and growth factors.
    Maiuri F; Cappabianca P; Gangemi M; De Caro Mdel B; Esposito F; Pettinato G; de Divitiis O; Mignogna C; Strazzullo V; de Divitiis E
    Neurosurg Focus; 2006 Jul; 21(1):e3. PubMed ID: 16859256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of familial cerebral cavernous malformations.
    Dashti SR; Hoffer A; Hu YC; Selman WR
    Neurosurg Focus; 2006 Jul; 21(1):e2. PubMed ID: 16859255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations.
    Sure U; Butz N; Schlegel J; Siegel AM; Wakat JP; Mennel HD; Bien S; Bertalanffy H
    J Neurosurg; 2001 Jun; 94(6):972-7. PubMed ID: 11409527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study.
    Labauge P; Krivosic V; Denier C; Tournier-Lasserve E; Gaudric A
    Arch Ophthalmol; 2006 Jun; 124(6):885-6. PubMed ID: 16769843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
    Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
    Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of a glioblastoma-associated tenascin-C isoform in cerebral cavernomas and neighboring vessels.
    Viale GL; Castellani P; Dorcaratto A; Pau A; Sehrbundt E; Siri A; Birò A; Zardi L
    Neurosurgery; 2002 Apr; 50(4):838-42; discussion 842. PubMed ID: 11904036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.
    Tirakotai W; Fremann S; Soerensen N; Roggendorf W; Siegel AM; Mennel HD; Zhu Y; Bertalanffy H; Sure U
    Childs Nerv Syst; 2006 Jul; 22(7):685-91. PubMed ID: 16489474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas.
    Reich P; Winkler J; Straube A; Steiger HJ; Peraud A
    Neurology; 2003 Apr; 60(7):1135-8. PubMed ID: 12682320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are cavernous sinus hemangiomas and cavernous malformations different entities?
    Gonzalez LF; Lekovic GP; Eschbacher J; Coons S; Porter RW; Spetzler RF
    Neurosurg Focus; 2006 Jul; 21(1):e6. PubMed ID: 16859259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral cavernous malformations: clinical insights from genetic studies.
    Mindea SA; Yang BP; Shenkar R; Bendok B; Batjer HH; Awad IA
    Neurosurg Focus; 2006 Jul; 21(1):e1. PubMed ID: 16859247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies.
    Kiliç T; Pamir MN; Küllü S; Eren F; Ozek MM; Black PM
    Neurosurgery; 2000 May; 46(5):1179-91; discussion 1191-2. PubMed ID: 10807251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy .
    Nimjee SM; Powers CJ; Bulsara KR
    Neurosurg Focus; 2006 Jul; 21(1):e4. PubMed ID: 16859257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain cavernoma: a dynamic lesion.
    Houtteville JP
    Surg Neurol; 1997 Dec; 48(6):610-4. PubMed ID: 9400644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial extra-axial cavernous (HEM) angiomas: tumors or vascular malformations?
    Biondi A; Clemenceau S; Dormont D; Deladoeuille M; Ricciardi GK; Mokhtari K; Sichez JP; Marsault C
    J Neuroradiol; 2002 Jun; 29(2):91-104. PubMed ID: 12297731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Société Française de Neurochirurgie.
    Labauge P; Laberge S; Brunereau L; Levy C; Tournier-Lasserve E
    Lancet; 1998 Dec; 352(9144):1892-7. PubMed ID: 9863787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
    Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma.
    Kleinman ME; Greives MR; Churgin SS; Blechman KM; Chang EI; Ceradini DJ; Tepper OM; Gurtner GC
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2664-70. PubMed ID: 17872454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients.
    Labauge P; Brunereau L; Lévy C; Laberge S; Houtteville JP
    Neuroradiology; 2000 May; 42(5):327-32. PubMed ID: 10872151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocorticography discharge patterns in patients with a cavernous hemangioma and pharmacoresistent epilepsy.
    Ferrier CH; Aronica E; Leijten FS; Spliet WG; Boer K; van Rijen PC; van Huffelen AC
    J Neurosurg; 2007 Sep; 107(3):495-503. PubMed ID: 17886546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical features and treatment of cerebral cavernous angiomas in children].
    Xie J; Ma Z; Luo S
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):407-9. PubMed ID: 11953209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.